Q4 2022 EPS Estimates for Colgate-Palmolive Boosted by Analyst (NYSE:CL)

Colgate-Palmolive (NYSE:CLGet Rating) – Analysts at Jefferies Financial Group lifted their Q4 2022 EPS estimates for Colgate-Palmolive in a research note issued to investors on Sunday, July 31st. Jefferies Financial Group analyst K. Grundy now anticipates that the company will post earnings per share of $0.83 for the quarter, up from their previous forecast of $0.82. The consensus estimate for Colgate-Palmolive’s current full-year earnings is $3.02 per share.

Several other equities research analysts have also recently issued reports on CL. Raymond James began coverage on shares of Colgate-Palmolive in a report on Thursday, April 7th. They issued a “market perform” rating on the stock. UBS Group raised their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock a “buy” rating in a report on Monday. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Colgate-Palmolive from $88.00 to $87.00 in a report on Tuesday, July 19th. Atlantic Securities cut shares of Colgate-Palmolive from an “overweight” rating to a “neutral” rating and dropped their target price for the stock from $92.00 to $80.00 in a report on Tuesday, May 3rd. Finally, StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Tuesday. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $84.57.

Colgate-Palmolive Price Performance

Shares of CL opened at $81.43 on Wednesday. The company has a market capitalization of $68.23 billion, a P/E ratio of 35.25, a price-to-earnings-growth ratio of 5.83 and a beta of 0.48. The company has a quick ratio of 0.72, a current ratio of 1.17 and a debt-to-equity ratio of 14.26. The firm has a 50 day moving average of $78.28 and a 200 day moving average of $78.36. Colgate-Palmolive has a twelve month low of $72.20 and a twelve month high of $85.61.

Colgate-Palmolive (NYSE:CLGet Rating) last announced its quarterly earnings results on Friday, July 29th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. The company had revenue of $4.48 billion during the quarter, compared to the consensus estimate of $4.35 billion. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.80 earnings per share.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Investors of record on Thursday, July 21st will be paid a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date of this dividend is Wednesday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 81.39%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, June 6th. The shares were sold at an average price of $79.34, for a total value of $3,967,000.00. Following the sale, the chief executive officer now directly owns 221,790 shares in the company, valued at approximately $17,596,818.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, insider John W. Kooyman sold 19,683 shares of the business’s stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $78.49, for a total value of $1,544,918.67. Following the sale, the insider now directly owns 7,007 shares in the company, valued at approximately $549,979.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $79.34, for a total transaction of $3,967,000.00. Following the completion of the sale, the chief executive officer now owns 221,790 shares in the company, valued at $17,596,818.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 79,683 shares of company stock worth $6,297,119. 0.31% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Colgate-Palmolive

A number of large investors have recently made changes to their positions in the company. Vestmark Advisory Solutions Inc. boosted its position in Colgate-Palmolive by 12.3% in the 4th quarter. Vestmark Advisory Solutions Inc. now owns 9,577 shares of the company’s stock valued at $817,000 after buying an additional 1,047 shares during the period. Ieq Capital LLC boosted its position in Colgate-Palmolive by 18.6% in the 4th quarter. Ieq Capital LLC now owns 11,841 shares of the company’s stock valued at $1,011,000 after buying an additional 1,861 shares during the period. Centaurus Financial Inc. boosted its position in Colgate-Palmolive by 9.3% in the 4th quarter. Centaurus Financial Inc. now owns 4,199 shares of the company’s stock valued at $358,000 after buying an additional 357 shares during the period. Capital Investment Advisory Services LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at about $254,000. Finally, Grimes & Company Inc. boosted its position in Colgate-Palmolive by 1.0% in the 4th quarter. Grimes & Company Inc. now owns 13,098 shares of the company’s stock valued at $1,118,000 after buying an additional 135 shares during the period. 78.12% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Company Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Want More Great Investing Ideas?

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.